News tagged with tumor response
CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer
Dec 01, 2009 |
not rated yet |
0
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University ...
Search results for tumor response
Tracking new cancer-killing particles with MRI
Nanotechnology / Nanomaterials
Dec 14, 2009 |
5 / 5 (4) |
0
Researchers at Rice University and Baylor College of Medicine (BCM) have created a single nanoparticle that can be tracked in real time with MRI as it homes in on cancer cells, tags them with a fluorescent ...
Clinical trial advances new approach to re-sensitizing breast cancer
Dec 13, 2009 |
not rated yet |
0
A new drug cocktail might be the right mix to fight breast cancer after it becomes resistant to standard therapy. Details of a new study supporting this approach suggest it's possible to re-sensitize tumors thus allowing ...
Obesity linked with poorer breast cancer outcomes
Dec 10, 2009 |
not rated yet |
0
Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.
Sonic Hedgehog variations linked to recurrence, survival and response to therapy of bladder cancer
Dec 09, 2009 |
not rated yet |
0
Genetic variations in the Sonic Hedgehog pathway increase the likelihood of recurrence, reduce survival time and limit response to therapy for people with non-muscle invasive bladder cancer, scientists from The University ...
Small addition to cancer drug may make big difference
Dec 08, 2009 |
3 / 5 (2) |
0
University of Florida researchers have found a way to use just a fraction of the normal dosage of a highly toxic, debilitating chemotherapy drug to achieve even better results against colon cancer cells.
Drug shows positive responses, low side-effects in multiple myeloma
Dec 07, 2009 |
not rated yet |
0
NEW ORLEANS ― The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers ...
Scientists discover genetic pattern that indicates early-stage lung cancer
Dec 01, 2009 |
4 / 5 (1) |
0
Wistar Institute researchers and collaborators from the University of Pennsylvania and New York University have identified immune system markers in the blood which indicate early-stage lung tumors in people at high risk for ...
Pancreatic tumors are marked for immunotherapy
Nov 30, 2009 |
not rated yet |
0
Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
Nov 30, 2009 |
not rated yet |
0
The University of Navarra Hospital (Spain) has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
Nov 25, 2009 |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
List of search results for tumor response
